Revolutionizing Transplant Management with Eurofins Transplant
April is National Donate Life Month, also known as Transplant Awareness Month—a time to honor the selfless donors who give the gift of life and to celebrate the strength and resilience of transplant recipients. Organ, eye, and tissue donation is a profound act of generosity, offering hope and healing to those in need. At Eurofins Viracor, we’re proud to play a vital role in supporting patients and providers through every stage of the transplant journey. As one of five companies comprising Eurofins Transplant, we collaborate with other specialized Eurofins companies—Eurofins CellTX, Eurofins Donor & Product Testing, Eurofins Ascend Clinical, and Eurofins Transplant Genomics—to deliver comprehensive solutions that span the full spectrum of transplant care. In recognition of this meaningful month, we’re highlighting how Eurofins Viracor, as a partner in Eurofins Transplant, is helping advance transplant science and care, working to support patients and providers at every step of the transplant journey.
At Eurofins Viracor, our focus is on providing advanced, high-sensitivity testing for infection detection, rejection monitoring, and immunosuppressive drug management—empowering care teams with the timely insights they need. Through innovation, precision, and a deep commitment to transplant science, we’re helping improve outcomes and quality of life for transplant patients. Together with our Eurofins partners, we're working toward a future where more patients can thrive with successful transplants.
Revolutionizing Transplant Management with Eurofins Transplant
Transplant management is a complex and continuous process that requires precise matching, early detection, and intuitive monitoring. From pre-transplant protocols and screenings to post-transplant diagnostics and rejection monitoring, the journey never stops. These crucial steps improve patient outcomes. That's where Eurofins Transplant comes in. By harnessing the power of artificial intelligence and innovative technologies, Eurofins Transplant is redefining transplant testing and delivering breakthrough solutions that empower both patients and providers.
Comprised of five key divisions within Eurofins—Eurofins CellTX, Eurofins Donor & Product Testing, Eurofins Ascend Clinical, Eurofins Viracor, and Eurofins Transplant Genomics—Eurofins Transplant covers every critical step in the transplant journey. Together, these essential clinical and diagnostic sectors form Eurofins Transplant.
Let’s dive deeper into the company overview of Eurofins Transplant to understand how they contribute to this groundbreaking field.
CellTX is solely dedicated to offering critical testing support for living donor-derived source material: stem cells, bone marrow, cord blood, birth tissues, egg, and sperm donations. The laboratory’s extensive testing menu supports organizations from donor source to transplantable cell-based products, regenerative medicines, and fertility applications.
CellTX is a vital division of Eurofins Transplant that specializes in providing innovative solutions for cell therapy. With the rapid advancements in regenerative medicine and cellular therapies, Eurofins CellTX plays a pivotal role in ensuring the safety, quality, and efficacy of these groundbreaking treatments. Through state-of-the-art testing and analysis, Eurofins CellTX enables characterization, potency assessment, and release testing of cellular products—ensuring they meet the rigorous standards necessary for successful transplantation.
By leveraging their expertise in cell biology, immunology, and molecular diagnostics, Eurofins CellTX empowers researchers, clinicians, and biopharmaceutical companies to advance the field of cell therapy and bring life-changing treatments to patients in need.
Eurofins Donor & Product Testing (DPT)
With over 35 years of experience in donor testing, Eurofins Donor & Product Testing is highly regarded for its expertise in providing comprehensive laboratory services to meet the unique needs of the transplant community.
Their test menu includes donor eligibility screening, HLA/immunogenetics, and microbiology testing. DPT offers a robust quality program, with certifications, licenses, and accreditations from CLIA, state agencies, ASHI, the Therapeutic Goods Administration (TGA), the German Health Authority, and FDA registration for HCT/Ps.
DPT provides critical testing for all donor suitability and eligibility determinations across 10 laboratories in the U.S., located in:
- Denver, CO
- Atlanta, GA
- Boston, MA
- Dallas, TX
- Honolulu, HI
- Los Angeles, CA
- San Ramon, CA
- Minneapolis, MN
- Philadelphia, PA
- Winston-Salem, NC
DPT offers testing support for critical transplant decisions 24 hours a day, 7 days a week, 365 days a year.
Ascend Clinical plays a pivotal role in the kidney transplant process, providing an extensive range of diagnostic services tailored for dialysis and transplant care. During the dialysis phase, Ascend performs regular testing to optimize treatment efficacy. These tests are crucial for adjusting treatment plans as needed, ensuring that patients remain in the best possible condition for a transplant.
Post-transplant, Ascend’s labs monitor for early signs of organ rejection and assess kidney function, contributing to effective transplant management and overall patient health. By offering continuous and detailed monitoring, Ascend Clinical ensures patients have the best support on their journey from dialysis to successful kidney transplantation.
Eurofins Viracor is another vital component of Eurofins Transplant. Specializing in advanced testing solutions that support precision and early detection in transplant management, Eurofins Viracor provides testing for infectious diseases, immunosuppression levels and toxicity monitoring, and identification of post-transplant subclinical or acute rejection.
Eurofins Viracor plays a crucial role in ensuring the safety and success of transplant procedures. By utilizing cutting-edge technologies and expert analysis, Eurofins Viracor delivers accurate and timely results, enabling healthcare professionals to make informed decisions throughout the transplant process.
Their commitment to innovation and comprehensive testing services for post-transplant and immunosuppressed populations has established Eurofins Viracor as a leading authority in transplant diagnostics. They provide the most comprehensive test menu for post-transplant patients, with industry-leading turnaround times.
Eurofins Transplant Genomics (TGI)
Eurofins Transplant Genomics is at the forefront of personalized treatment strategies for transplant patients. Working alongside the transplant community and within the Eurofins family, TGI is commercializing a suite of tests designed to improve the quality of life for transplant recipients.
TGI is committed to improving organ transplant outcomes worldwide through innovative tests that detect early signs of graft injury, differentiate among actionable causes, and enable therapy optimization. Leveraging the power of genomics and molecular profiling, Transplant Genomics aims to tailor treatment plans based on individual genetic markers.
By identifying genetic signatures related to immune system function and response, Transplant Genomics empowers healthcare providers to make informed decisions regarding immunosuppressive therapies and post-transplant monitoring. This personalized approach not only enhances patient care but also mitigates the risk of organ rejection—ultimately improving long-term transplant success rates.
By bringing these five entities together, Eurofins Transplant is revolutionizing transplant management through comprehensive solutions that span the entire transplantation journey. They are committed to accuracy and reliability—ensuring precise matching, early detection, and personalized treatment for transplant patients.
Combining advanced technologies, artificial intelligence, and expert analysis, Eurofins Transplant equips healthcare professionals with the tools they need to make informed decisions and manage the complexities of transplant care. Through their unwavering commitment to innovation and patient-centric care, Eurofins Transplant is paving the way for a future where successful transplant outcomes are within reach for more individuals in need.
Eurofins Transplant… a step ahead in transplant testing.
Your Partner Through Every Step of the Transplant Journey
